Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc. anticipates significant growth in its net PLGL liability, projected to increase from $78 million at year-end 2024 to between $145 million and $165 million by the end of 2025, indicative of robust operational positioning. The company continues to benefit from a strong demand for behavioral health services, leveraging organic growth opportunities through bed expansions and new facility developments, while maintaining strong capitalization for potential mergers and acquisitions. Additionally, guidance suggests an expected improvement in organic earnings growth, pointing to a favorable outlook for the company amid rising claims activity and strategic operational enhancements.

Bears say

Acadia Healthcare Co Inc has experienced a series of downward revisions in its financial guidance, with EBITDA projections for 2025 reduced by approximately 13.4% to a new range of $601-611 million largely due to higher-than-expected PLGL expenses. The company anticipates that these elevated expenses will persist into 2026, leading to a projected adjusted EBITDA of $626.6 million, down from previous estimates of $664.6 million. Additionally, the persistent softness in volume is expected to negatively impact performance, contributing to a scenario where FY26 EBITDA may be 5% below current estimates, resulting in compression of the enterprise multiple to 5.0x, significantly lower than historical averages for acute care hospitals.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.